ABSTRACT: In this work a photosubstitution strategy is presented that can be used for the isolation of chiral organometallic complexes. A series of five cyclometalated complexes Ru(phbpy)(N−N)(DMSO-κS)](PF 6 ) ( 
■ INTRODUCTION
Since the clinical approval of cisplatin a great number of inorganic complexes with anticancer properties have been described, among which several ruthenium complexes have reached clinical trials. Currently, most research is focused on either compounds based upon the piano-stool Ru(II)η 6 -arene scaffold pioneered by the groups of Dyson and Sadler 1,2 or ruthenium(II) polypyridyl complexes, of which several (photoactive) candidates have been developed by the groups of Dunbar, 3 Gasser, 4 Glazer, 5 Renfrew, 6 Keyes, 7, 8 Kodanko, 9, 10 or Turro. 11 More recently cyclometalated analogues of these complexes have emerged as a new subclass of light-activatable anticancer complexes. 3, 12, 13 In this type of compounds, one nitrogen atom in a polypyridyl ligand has been replaced by a carbon atom, resulting in an organometallic metallacycle. 14−17 As a consequence, cyclometalated compounds often show enhanced properties for chemotherapy or photodynamic therapy (PDT) than their noncyclometalated analogons. 14 In particular, the lower charge of cyclometalated complexes leads to an increased lipophilicity, which in turn increases uptake in cancer cells 18 and often leads to higher cytotoxicity 19 toward cancer cells. In addition, cycloruthenated polypyridyl complexes have increased absorption in the red region of the spectrum, which is excellent for photochemotherapy. Whereas polypyridyl ruthenium complexes typically absorb between 400 and 600 nm, 20 a bathochromic shift is usually observed for cyclometalated compounds due to the destabilization of t 2g orbitals by the π-donating cyclometalated carbanionic ligand, potentially allowing activation of these compounds in the photodynamic window, (600−1000 nm) where light penetrates further into biological tissue. 21 Although cyclometalation often leads to a significant decrease of the photosubstitution properties of ruthenium complexes, the group of Turro has reported two cyclometalated complexes, cis-[Ru(phpy)(phen)-(MeCN) 2 ]PF 6 and cis-[Ru(phpy)(bpy)(MeCN) 2 ]PF 6 , (phpy = 2-phenylpyridine), that are capable of exchanging their acetonitrile ligand upon light irradiation and are phototoxic in cancer cells. 22 Inspired by this work and following our investigation of caged ruthenium complexes with the general formula [Ru-(tpy) 
2+ in which L is a sulfur-based ligand and tpy = 2,2′;6′,2″-terpyridine, we herein investigated the preparation and properties of cycometalated analogues of this family of complexes where the carbanion is introduced in the tridentate ligand. Five complexes [1] PF 6 −[5]PF 6 with the general formula [Ru(phbpy)(N−N)(DMSO-κS)]PF 6 with Hphbpy = 6′-phenyl-2,2′-bipyridyl and N−N = bpy (2,2′-bipyridine, [1] PF 6 ), phen (1,10- 2+ by a carbon ligand, these ruthenium complexes become chiral, and using chiral monodentate sulfoxides should allow for separating their diastereomers. 23−25 However, these cyclometalated complexes turned out to be substitutionally inert under thermal conditions, preventing displacement of DMSO in the racemic precursor. In order to achieve the resolution of [1]PF 6 , it was therefore necessary to design a photochemical route. By investigating the photophysical properties and photoreactivity of these complexes, three of these complexes were found suitable for this approach, of which one was resolved using a chiral monodentate sulfoxide ligand. 3 (DMSO-κO)], the reaction of the bidentate ligand N−N = bpy, phen, dpq, dppz, or dppn was realized first, followed by cyclometalation using Hphbpy in the presence of a catalytic amount of N-methylmorpholine, affording the five compounds [Ru(phbpy)(N−N)(DMSO-κS)]PF 6 6 , and toluene in DCM for [4] PF 6 . All compounds crystallized in space groups having an inversion center, thus containing a (1:1) mixture of enantiomers. A selection of bond lengths and angles is shown in Table 1 . As expected, the ruthenium centers in these compounds have a distorted octahedral geometry similar to that of their terpyridyl analogues. 27 Compared to [Ru(tpy)(bpy)(DMSO-κS)](OTf) 2 replacing the nitrogen within this scaffold with an anionic carbon atom has only a modest effect on the corresponding bond length, with Ru1−C1 in [1]PF 6 (2.043(2) Å) being almost as long as Ru1−N1 in its terpyridine analogue (2.079 Å). 28 Furthermore, compared to its noncyclometalated analogon the trans-influence of the carbon atom in phbpy − results in an elongation of the Ru1−N2 bond length in [Ru(phbpy)(bpy)(DMSO-κS)] 2+ (2.173(2) Å), whereas in [Ru(tpy)(bpy)(DMSO-κS)] 2+ the Ru1−N3 length is 2.073(3) Å. 29 In contrast, the ruthenium−sulfur bond length is shorter Photosubstitution. Replacing the DMSO ligands in these complexes was therefore attempted photochemically, monitoring the reaction using 1 H NMR. When a sample of [2]PF 6 was irradiated in acetonitrile with white light (hν ≥ 410 nm, Scheme 3), a clean photoconversion to a new species was observed, which was confirmed to be the acetonitrile adduct by mass spectrometry. As shown in Figure 3 6 were not photosubstitutionally active, in contrast to the noncyclometalated analogons [Ru(tpy)(dppz)-(SRR′)] and [Ru(tpy)(dppn)(SRR′)] (SRR′ = 2-(2-(2-(methylthio)ethoxy)ethoxy)ethyl-β-D-glucopyranoside) 27 that both exchange their thioether ligand upon light irradiation. 27 Resolving Diastereomers. The photoactivity of [1]PF 6 − [3]PF 6 therefore allowed us to investigate separation of their 
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Article sequent purification over a reverse phase HPLC column afforded [11- Figure S6) . 1 H NMR confirmed that fraction 1 corresponded to the R-C diastereomer, which is most apparent because of its more shielded α-proton of phen appearing at 10.64 ppm (Figure 4) . Fraction 2 contained the R-A diastereomer, with a doublet appearing at 10.74 ppm (Figure 4 ). This deshielding effect on the α-proton on phen is most likely attributed to the interaction of the tolyl group with the bidentate ligand. This assumption was supported by NOESY experiments ( Figure  S8 ), which showed the absence of interaction between the methyl of the sulfoxide and phen, whereas a weak interaction was observed for [11- 32 Around 450 nm, either positive or negative Cotton effects were observed for [11-A]PF 6 or [11-C]PF 6 , respectively, which must originate from the 1 MLCT transitions. Theoretically, resolution of these complexes by performing blue light irradiation in acetonitrile may be tempting. However, photosubstitution is usually accompanied by racemization of the coordination sphere, so that thermal ligand substitution would be preferred. 33 This was however not possible due to the exceptional thermal stability of the sulfoxide cyclometalated complexes (see above) that prevented thermal displacement of the chiral sulfoxide to obtain isolated enantiomers of [A-7] + , [C + was not straightforward to understand, and therefore a full photophysical characterization of the five complexes was carried out. The electronic absorption spectra ( Figure S1 ) of these complexes show that they have a considerable bathochromic shift (∼40 nm, Table 3 ) and a significant broadening of their 1 MLCT band compared to [9] 2+ (411 nm, Table 3 ). [4] + and [5] + have additional absorption bands around 370 and 410 nm, respectively. These are most likely π−π* transitions arising from the dppz and dppn ligand. The spectra of [6] + − [8] + in acetonitrile also showed a shift of the 1 MLCT band of ∼50 nm compared to [10] 2+ . This bathochromic shift is common for cyclometalated ruthenium complexes 12, 34 and is mostly ascribed to an increase in the energy of the highest occupied molecular orbital (HOMO, t 2g ). ). This decreased reactivity is most likely caused by the destabilization of the 3 MC state due to increased electron density at the metal center brought by the strong σ-donor C atom, whereas stabilization of the 3 MLCT leads to a larger energy gap between the 3 MLCT and 3 MC state, therefore making thermal population of the latter rather unlikely. 34 This interpretation is supported by previous work of the Turro group, who has demonstrated that the efficiency of the photosubstitution in sterically congested cyclometalated complexes is very low or absent. 12, 22 Second, emission maxima (λ em ) and emission quantum yields (Φ P ) for [1]PF 6 −[5]PF 6 were measured in acetonitrile (Table 3 ). All compounds were found very weakly emissive 
Article with a slightly higher phosphorescence quantum yield compared to the polypyridyl complex [Ru(phbpy)(tpy)]
). 35 The emission wavelengths found for [ 2 were determined with cyclic voltammetry (Figure 7 and Table  4 ) to provide insight into the frontier orbitals of the cyclometalated complexes. 38 As summarized in the low-lying, reversible oxidation suggests that the Ru(dπ)-based HOMO of the cyclometalated complexes is very high in energy, due to the π-donating character of the phbpy − ligand. 12 As the irreversibility of the oxidation of [9] (PF 6 ) 2 is attributed to linkage isomerization of DMSO from S-bound to O-bound, 39 cyclometalation also appears to prevents redox-induced linkage isomerization of the DMSO ligand, most likely due to the increased electron density on ruthenium. 6 ) due to the strong electron-accepting properties of the dipyridophenazine moieties. These first reductions being essentially reversible, the LUMO of these two complexes is dppz-or dppn-based, respectively. 41 The experimental HOMO − LUMO gaps ΔE exp , which can be approximated, for quasireversible redox couples, to the difference between E ox and E red (Figure 7, left) , followed similar trends to the theoretical HOMO − LUMO gaps ΔE th calculated by DFT (Table 4) . ΔE th were found very comparable indeed for complexes [1]PF 6 −[3]PF 6 (ΔE exp ≈ 2.2 V and ΔE th ≈ 3.6 V) and much higher than that of [4]PF 6 and [5]PF 6 (ΔE exp = 1.8 and 1.6 V, respectively, and ΔE th = 3.13 and 1.86 V). The particularly low value of ΔE found for [4]PF 6 and [5]PF 6 suggested that the dppz and dppn ligands may generate low-lying excited states, which would explain the absence of photosubstitution with these two complexes.
To confirm this hypothesis, density functional theory (DFT) calculations were performed for [1] + − [5] + at the PBE0/TZP/ COSMO level. The calculated HOMO energy, LUMO energy, and ΔE th = E LUMO − E HOMO of the minimized geometries followed the same trend as the experimental values (Table 4 and Figure 7b ). For [1] + and [2] + the LUMO was located on 
Article the phbpy − ligand, for [4] + and [5] + it was localized on the dppz and dppn bidentate ligand, respectively (Figure S3−5), whereas for [3] + empty orbitals localized both on phbpy − and dpq were found close in energy and near the LUMO level. Thus, like for the terpyridine series, 41 extending the conjugation of the bidentate ligand in the cyclometalated series [1] + to [5] + resulted in a strong stabilization of the LUMO in [4] + and [5] + , and in a shift of its localization, from the tridentate ligand in [1] + and [2] + to the bidentate ligand in [4] + and [5] + , with [3] + as borderline species (Figure 7b ). The strong stabilization of the LUMO in [4] + and [5] + generates low-lying excited states, most likely of , while it is absent in the more conjugated analogues [4] + and [5] + . The photoreactivity of ruthenium complexes is result of a delicate interplay of excited states of different natures and energies. In [1] + , [2] + , and [3] + the emission maximum was close to 800 nm, irrespective of the nature of the bidentate ligand, because the 3 MLCT excited states must be located on the phbpy ligand. By contrast, in the more conjugated complexes [4] + and [5] + the emission maxima depend significantly on the bidentate ligand, with a higher energy (λ em = 618 nm) for the less conjugated dppz complex, compared to dppn (λ em = 672 nm, see Table 3 ). Two results are apparently contradictory: the higher energy of the emitting ( 3 MLCT) excited states vs the very low calculated and experimental ΔE values in [4] + and [5] + , compared to [1] + , [2] + , and [3] + . This contradiction suggests that the lower triplet states centered on dppz and dppn and arising from the photochemical population of the low-lying LUMO-like orbitals are not emissive; they are probably of 3 π−π* character and centered on the phenazine moiety of the dppz or dppn ligand. The weakly emissive states, on the other hand, most likely of 3 MLCT character, are higher in energy in [4] + and [5] + because they are centered on the bpy moiety of dppz or dppn, while in [1] + , [2] + , and [3] + they are centered on the more conjugated phenyl-functionalized bipyridine ligand. All in all, the ligand photosubstitution reactions occur from metalcentered 3 MC states, which are high in energy for [1] + − [5] + due to the excellent σ-donor properties of the cyclometalated ligand and probably poorly dependent on the conjugation of the bidentate ligand. Due to the presence of their low-lying 3 π−π* states, [4] + and [5] + cannot perform any photosubstitution, as nonradiative decay pathways are faster. 42 For [1] + , [2] + , and [3] + these 3 π−π* states are much higher in energy, so that the photogenerated, low-lying phbpy-based 3 MLCT states, in spite of the higher-lying 3 MC states, still leads to photosubstitution, though at a significantly lower rate than in the terpyridine analogue [9] 2+ . Chiral-at-metal complexes based upon ruthenium, iridium, or rhodium have been extensively investigated by the group of Meggers, 43−45 Barton, 46 and others 47−49 and have shown great promise in, e.g., asymmetric (photo)catalysis 50, 51 or as anticancer drugs. 52 To resolve these types of complexes, a classical method consists of coordinating an enantiomerically pure chiral auxiliary to the metal center, resulting in a mixture of diastereomers which can be separated in preparative scales using normal phase chromatography such as silica. 53 After separation, these diastereoisomers are typically treated with an achiral monodentate ligand of interest, thus resolving the two pure enantiomers. Other resolution methods involve direct recrystallization of enantiomers using chiral counterions such 
Article as Δ-TRISPHAT, 32,54−56 or separation of the enantiomers on chiral HPLC. 46 For [1] + − [5] + these strategies could not be followed due on the one hand to the exceptional inertness of the coordination sphere and possibly to the very similar molecular shape of the cyclometalated vs. pyridyl side of the ruthenium-coordinated phbpy ligand. We hence relied on photochemical substitution to introduce a chiral sulfoxide ligand as resolving agent. The resulting diastereoisomeric ruthenium complexes [11-A]PF 6 and [11-C]PF 6 were inseparable on normal-phase silica. We therefore diverted to the use of reverse phase HPLC using 0.1% formic acid in the eluent. As a result, the isolation of the two diastereoisomers as their formate complexes was possible, but the presence of formic acid affected the overall yield (9%), most likely due to partial reprotonation of the cyclometalated ligand and subsequent (partial) degradation of the products. This is an issue that will be addressed in the future.
■ CONCLUSION

Replacing the terpyridine tridentate ligand in [Ru(tpy)(NN)-L]
2+ with phbpy has led to a new family of chiral-at-metal complexes [1] + − [5] + with drastically altered thermal and photochemical properties compared to their polypyridine analogues. In particular, thermal substitution of the monodentate sulfoxide ligands becomes virtually impossible, while the ligand photosubstitution efficiency was reduced or even quenched due to the strong effect of cyclometalation on the energy of the HOMO and LUMO of the complexes. When N−N is a phenazine-based ligand ( [4] + or [5] + ), the LUMO is based on the bidentate ligand and full quenching of the photoreactivity occurred, in great contrast to the photochemical behavior of terpyridine analogues such as [Ru(tpy)-(dppz)(SRR')] 2+ or [Ru(tpy)(dppn)(SRR')] 2+ that undergo selective photosubstitution in water (Φ 450 = 0.02 27 and 0.00095, 36 respectively). The resolution of photosubstitutionally and thermally inert chiral cyclometalated complexes such as [4] + and [5] + will thus require strategies that still need to be developed. However, when N−N is bpy, phen, or dpq ( [1] + − [3] + ), selective photosubstitution of DMSO by acetonitrile remained possible. The ability of [1] + − [3] + to exchange DMSO by acetonitrile upon visible light irradiation can be exploited, as demonstrated here with [2] + , to labilize the thermally inert achiral DMSO ligand and replace it in two steps by a chiral sulfoxide ligand, thus allowing the separation of the two chiral isomers [11-A] + and [11-C] + . This works demonstrates that photosubstitution reactions can be useful for the resolution of chiral-at-metal organometallic complexes, which opens new synthetic routes toward catalytically or biologically active chiral organometallic complexes.
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